Biotech · Private company
Antiva Biosciences
Track this companyFree. Adds Antiva Biosciences to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- ABI-1968Phase 1 · HSILClinicalTrials.gov · fetched Nov 12, 2026
- ABI-1968Phase 1 · HSIL, High-Grade Squamous Intraepithelial LesionsClinicalTrials.gov · fetched Nov 12, 2026
- Topical ABI-1968 creamPhase 1 · HSIL, High-Grade Squamous Intraepithelial LesionsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) InfectionPHASE1 · TERMINATED · started Dec 17, 2018ClinicalTrials.gov NCT03677960 · fetched Nov 12, 2026
- Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) InfectionPHASE1 · COMPLETED · started Jan 1, 2018ClinicalTrials.gov NCT03239223 · fetched Nov 12, 2026
- Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) InfectionPHASE1 · COMPLETED · started Aug 11, 2017ClinicalTrials.gov NCT03202992 · fetched Nov 12, 2026